Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Neuralstem, Inc.
Neuralstem shares spiked 7.5 percent on over 1.2 million shares traded Friday. The company reported that President and CEO Richard Garr will present a 2013 trials overview at the fifth annual Biotech Showcase in San Francisco on Tuesday, January 8th.
Going forward ... (see research report)








